Invesco Biotechnology & Genome ETF (PBE) Holdings history

Fund Profile

Current holdings

Data for period

31 Jul 24

(Last reporting period)

Total assets

$324.15 mm

Liabilities

$54.27 mm

Net assets

$269.88 mm

Number of holdings

33.00

Holding trends

Total assets and liabilities

Assets

Liabilities

Total number of holdings

Holdings history data

$Dollar values in millions. Negative values are Short positions. "0" is less than $100,000.

Filter holdings

All historic holdings

Current

Data to display

$Value

#Units

%Holdings

Shade data

Download data

Holding	Oct 19	Jan 20	Apr 20	Apr 20	Jul 20	Oct 20	Jan 21	Apr 21	Jul 21	Oct 21	Jan 22	Apr 22	Jul 22	Oct 22	Jan 23	Apr 23	Jul 23	Jan 24	Apr 24	Jul 24
Abbott Laboratories
AbbVie, Inc.
Acadia Pharmaceuticals Inc.
Acceleron Pharma, Inc.
Akebia Therapeutics, Inc.
Alexion Pharmaceuticals, Inc.
Alkermes PLC
Amgen Inc.
Amicus Therapeutics, Inc.
Amphastar Pharmaceuticals, Inc.
Anavex Life Sciences Corp.
ANI Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Avid Bioservices, Inc.
Bausch Health Cos. Inc.
Bio-Techne Corp.
Biogen Inc.
BioMarin Pharmaceutical Inc.
Blueprint Medicines Corp.
Bristol-Myers Squibb Co.
Cardiovascular Systems, Inc.
CareDx, Inc.
Cassava Sciences, Inc.
Catalent, Inc.
Catalyst Pharmaceuticals, Inc.
Celgene Corp.
Celldex Therapeutics, Inc.
ChemoCentryx, Inc.
Coherus Biosciences, Inc.
Collegium Pharmaceutical, Inc.
Compugen Ltd.
Corcept Therapeutics, Inc.
CRISPR Therapeutics AG
CymaBay Therapeutics, Inc.
Cytokinetics, Inc.
Dicerna Pharmaceuticals, Inc.
Dynavax Technologies Corp.
Eagle Pharmaceuticals, Inc.
Eli Lilly and Co.
Emergent BioSolutions Inc.
Enanta Pharmaceuticals, Inc.
Endo International PLC
Esperion Therapeutics, Inc.
Exelixis, Inc.
EyePoint Pharmaceuticals, Inc.
Fate Therapeutics, Inc.
FibroGen, Inc.
Five Prime Therapeutics, Inc.
Fluidigm Corp.
Fulgent Genetics, Inc.
Genomic Health, Inc.
Gilead Sciences, Inc.
Halozyme Therapeutics, Inc.
Horizon Therapeutics PLC
Illumina, Inc.
ImmunoGen, Inc.
Incyte Corp.
Innoviva, Inc.
Insmed, Inc.
Intellia Therapeutics, Inc.
Intra-Cellular Therapies, Inc.
Invesco Government & Agency Portfolio
Invesco Liquid Assets Portfolio
Invesco Premier U.S. Government Money Portfolio
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
INVESCO PRIVATE GOVERNMENT FUND INVESCO PRIVATE GOVERNMENT FUND
INVESCO PRIVATE GOVERNMENT FUND INVESCO PRIVATE GOVERNMENT FUND
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
INVESCO PRIVATE PRIME FUND INVESCO PRIVATE PRIME FUND
INVESCO PRIVATE PRIME FUND INVESCO PRIVATE PRIME FUND
Ionis Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
Jazz Pharmaceuticals PLC
Johnson & Johnson
Ligand Pharmaceuticals, Inc.
MannKind Corp.
Merck & Co., Inc.
Mylan N.V.
MyoKardia, Inc.
Myriad Genetics, Inc.
Natera, Inc.
Nektar Therapeutics
Neurocrine Biosciences, Inc.
Novavax, Inc.
OPKO Health, Inc.
Pacific Biosciences of California, Inc.
Pacira BioSciences, Inc.
Perrigo Co. PLC
Pfizer, Inc.
Portola Pharmaceuticals, Inc.
Precigen, Inc.
Prestige Consumer Healthcare Inc.
Prothena Corp. PLC
PTC Therapeutics, Inc.
Qiagen N.V.
Radius Health, Inc.
Regeneron Pharmaceuticals, Inc.
REGENXBIO Inc.
Repligen Corp.
Sage Therapeutics, Inc.
Sangamo Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Seagen, Inc.
Supernus Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd.
TG Therapeutics, Inc.
United Therapeutics Corp.
Vanda Pharmaceuticals, Inc.
Veracyte, Inc.
Vericel Corp.
Vertex Pharmaceuticals Inc.
Viking Therapeutics, Inc.
Voyager Therapeutics, Inc.
Xencor, Inc.
Xenon Pharmaceuticals Inc.